High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies

BACKGROUND: Adoptive transfer of engineered T cells has shown remarkable success in B-cell malignancies. However, the most common strategy of targeting lineage-specific antigens can lead to undesirable side effects. Also, a substantial fraction of patients have refractory disease. Novel treatment ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Çınar, Özcan, Brzezicha, Bernadette, Grunert, Corinna, Kloetzel, Peter Michael, Beier, Christin, Peuker, Caroline Anna, Keller, Ulrich, Pezzutto, Antonio, Busse, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327818/
https://www.ncbi.nlm.nih.gov/pubmed/34330762
http://dx.doi.org/10.1136/jitc-2021-002410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327818/
https://www.ncbi.nlm.nih.gov/pubmed/34330762
http://dx.doi.org/10.1136/jitc-2021-002410

Ejemplares similares